Nasdaq soars nearly 3% as stocks rebound from correction, but S&P posts 4-week skid
Wall Street's major averages rebounded strongly on Friday, a day after stocks closed in correction territory as President ...
Nasdaq, S&P, and Dow are mixed as retail inflation cools more than expected
Wall Street's major averages trade mixed on Wednesday as retail inflation slowed more than expected in February along with ...
moneycontrol.com2y
Nasdaq Technical Analysis
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...
Nasdaq, S&P, and Dow rise a day after Wall Street closes in correction territory
Wall Street's major averages pushed higher on Friday, a day after Wall Street closed in correction territory as Donald ...
You'll soon be able to trade 24 hours a day during the week if Nasdaq gets its way
The NYSE and Cboe have both made similar announcements in recent months, as US exchanges look to enable greater global ...
Nasdaq1mon
Humacyte To Submit IND Application For Small-Diameter ATEV In Coronary Bypass Surgery
(RTTNews) - Humacyte, Inc. (HUMA), a biotechnology company, Tuesday announced its plan to file an Investigational New Drug or IND application ... reflect those of Nasdaq, Inc. Founded in the ...
Nasdaq1mon
FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases
Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug (IND) application to begin clinical studies on its investigational CRISPR-based allogenic CAR-T ...
Nasdaq, S&P, Dow futures rise on hopes for tariff-relief deal
Stock index futures climbed on Wednesday as Commerce Secretary Howard Lutnick stoked hopes for a tariff-relief deal. Tariffs are triggering volatility. Don’t wait for tomorrow’s headlines—get the ...
Karolinska Development's portfolio company PharmNovo receives positive FDA feedback prior to IND application for Phase 2a trial
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that portfolio company PharmNovo received positive feedback regarding its most advanced drug candidate, PN6047, in a pre-IND meeting ...